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AMONG the causes for chronic enteropathies (CE) in dogs, food-responsive diarrhoea (FRD), 
antibiotic-responsive diarrhoea (ARD) and steroid-responsive disease (SRD) are common 
(Allenspach and others 2007, Simpson and Jergens 2011). These disorders are diagnosed 
retrospectively by their response to treatment. Prevalence data regarding how many dogs 
can be categorised into each group are scarce as are clinical data describing the 
characteristics of a typical patient in each of these groups (Craven and others 2004, 
Muenster and others 2006, Allenspach and others 2007). Furthermore, only a few studies to 
date have investigated more long-term outcome in the different treatment categories 
(Allenspach and others 2006, 2007). The goal of this retrospective study was, therefore, to 
compare severity of clinical signs, age at diagnosis, serum albumin concentrations, serum 
cobalamin and folate concentrations as well as outcome at various time points after 
diagnosis between a group of dogs treated with dietary management alone (FRD), diet and 
antimicrobials (ARD) or diet and immunosuppressive agents (SRD) in a larger cohort of dogs. 
 
The electronic medical records at the Royal Veterinary College, London, were searched for 
dogs diagnosed with CE between 2005 and 2012. The diagnosis was confirmed based on 
exclusion of any other causes for chronic diarrhoea, and endoscopy followed by 
histopathological findings of intestinal mucosal biopsies confirming lymphoplasmacytic, 
eosinophilic or mixed inflammation. In addition, at the time of diagnosis, all dogs had to 
have a clinical scoring index (Canine Chronic Enteropathy Clinical Activity Index (CCECAI); 
Allenspach and others 2007) recorded by the attending clinician in order to be included into 
the study. 
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In total, 203 dogs were included in the study. FRD was defined as dogs that responded to 
elimination diet alone within two weeks after initiating therapy and that had been kept on a 
strict dietary regimen for 12 weeks after diagnosis. All FRD dogs were then switched back to 
the diet they had been previously consuming. Dogs with ARD were defined as having failed 
to respond to a novel antigen of hydrolysed dietary trial before referral and responded to 
metronidazole within two weeks after initiation of therapy. Dogs with SRD were defined as 
those that had an unsuccessful dietary and antimicrobial trial with either metronidazole or 
tylosin before referral, and required immunosuppressive therapy to control their clinical 
signs, with a number of combinations of prednisolone, cyclosporine and azathioprine 
treatment being included in this group. At the time of diagnosis, CCECAI, age, serum 
albumin, folate and cobalamin concentrations were recorded. Outcome data were defined 
as no improvement or only slight improvement, or moderate to marked improvement, and 
were extracted from the medical record database, when available, at 2–4 weeks, 4–8 weeks, 
8–12 weeks and at 12 weeks to 6 months after diagnosis. Outcome data at 6–12 months 
were collected by telephone interviews to owners and referring veterinarians and were 
defined as improved or not improved compared with at time of diagnosis. Data were 
evaluated for normal distribution, and statistical analysis between groups was performed 
using a Kruskal–Wallis followed by Dunn's post hoc test for numerical data or χ2 test for 
categorical data, respectively. 
 
The FRD group consisted of 131 dogs (64%), whereas the ARD and SRD groups consisted of 
33 (16.2%) and 39 dogs (19.2%), respectively. Diets prescribed in the FRD dogs included an 
elimination diet in 73 cases (55%), a hydrolysed diet in 58 cases (44%) and a home-cooked 
diet in 2 cases (1%). Median age at diagnosis was significantly different between the FRD 
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and SRD dogs, and between the ARD and SRD dogs (FRD median 3 years, range 0–12, ARD 
median 2, range 0–11, SRD median 6, range 1–13, P≤0.001). Serum albumin concentration 
was significantly different between the FRD and SRD groups (mean FRD 3.2±SD 5.8; SRD 
2.6±SD 9.0; P≤0.001; reference range 2.8–3.9 g/dl); however, serum folate and cobalamin 
concentrations were not different between groups (cobalamin: FRD median 360 (range 146–
1127), ARD median 402 (range 150–1200), SRD median 245 (range 156–1200), normal value 
>200 ng/l, P=0.17; folate: FRD: median 12.05 (range 2.5–24), ARD median 12.4 (range 2.1–
20.2), SRD median 13.6 (range 3.4–23.3), P=0.31, reference range 6.5–11.5 ng/ml). CCECAI 
at diagnosis was significantly different between the FRD and ARD groups, and between the 
FRD and SRD groups (median FRD 6, range 2–12; median ARD 8, range 0–14; median SRD 9, 
range 5–14, P≤0.001). Outcome was significantly better for FRD versus ARD and for FRD v 
SRD at 2–4 weeks after discharge from the hospital (P<0.001 and P=0.002). At 4–8 weeks 
after discharge, outcome was significantly better in FRD versus ARD (P<0.001), and at six 
months to one year, outcome was also significantly better for FRD versus ARD and for FRD 
versus SRD (P<0.001 and P=0.002). There was no statistically significant difference in 
outcome between dogs that received an elimination diet or a hydrolysed diet (P=0.7). 
 
The data presented in this study confirm previous findings that FRD dogs comprise 
approximately 2/3 of dogs presenting with CE in a secondary to tertiary referral population 
(Craven and others 2004, Allenspach and others 2007). ARD dogs were the youngest, 
followed by FRD and SRD dogs, which concurs with previous studies (Muenster and others 
2006, Allenspach and others 2007). Clinical severity at the time of diagnosis was significantly 
different between the groups, again with FRD having the lowest clinical scores. This is 
consistent with some previous reports (Muenster and others 2006), but not with others 
 5 
(Allenspach and others 2007). Mean serum albumin concentrations were significantly 
decreased in SRD compared with FRD, which could be due to the fact that more severely 
affected animals are more prone to develop a degree of protein-losing enteropathy or 
chronic malnutrition. Outcome in FRD dogs was very good in the first year after diagnosis in 
this cohort of dogs, which confirms previous findings that a response to elimination diet or 
hydrolysed diet within two weeks should prompt a strict dietary regimen for at least 12 
weeks after diagnosis (Allenspach and others 2007). However, current treatment for ARD 
and SRD seems unsatisfactory and studies need to be designed to look at long-term 
response in dogs with CE to get a better understanding on how to treat these dogs. 
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